Original disclosure @ IFC website
Updated in EWS Mar 11, 2019
Disclosed by Bank Mar 1, 2019
Can you contribute information about this project?
Contact the EWS Team
The proposed project entails an IFC equity commitment of up to US$20 million, not to exceed 20% of total commitments, in Adjuvant Global Health Technology Fund L.P. (“The Fund”), a 10-year closed-end fund raising US$200 million to make equity, mezzanine and debt investments in companies or projects developing solutions for overlooked public health challenges.
Adjuvant Global Health Technology Fund L.P.
Mr. Glenn Rockman
+1 917 334 0724
501 5th Avenue, Suite 1404, New York, NY 10017
ACCOUNTABILITY MECHANISM OF IFC
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org. You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org/